Company profile for HUYA Bioscience International

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

HUYA Bioscience International® is the leader in enabling and accelerating the global development of novel biopharmaceutical product opportunities originating in China. Extensive collaborations are established with Chinese biopharmaceutical, academic and commercial organizations to speed development and value creation in worldwide markets for China-sourced product candidates. With the largest Chinese compound portfolio coverin...
HUYA Bioscience International® is the leader in enabling and accelerating the global development of novel biopharmaceutical product opportunities originating in China. Extensive collaborations are established with Chinese biopharmaceutical, academic and commercial organizations to speed development and value creation in worldwide markets for China-sourced product candidates. With the largest Chinese compound portfolio covering all therapeutic areas, HUYABIO has emerged as the partner-of-choice for maximizing the value of biopharmaceutical innovation in China. HUYABIO has offices in the US, Japan, South Korea, and eight strategic locations.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Shanghai Zhangjiang, Hi-Tech Park 780 Cailun Road, Suite 805, Pudong, Shanghai...
Telephone
Telephone
+86 21 5132 3312
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/huyabio-intl-presents-positive-clinical-results-from-hbi-3000-phase-2a-clinical-trial-of-novel-multi-ion-channel-blocker-for-acute-atrial-fibrillation-302437026.html

PR NEWSWIRE
24 Apr 2025

https://www.contractpharma.com/breaking-news/huyabio-taps-paul-spreen-as-chief-business-officer/

CONTRACTPHARMA
18 Mar 2025

https://www.prnewswire.com/news-releases/huyabio-international-announces-appointment-of-paul-spreen-as-chief-business-officer-302404022.html

PR NEWSWIRE
18 Mar 2025

https://www.prnewswire.com/news-releases/huyabio-validates-protective-mechanism-for-antiarrhythmic-drug-hbi-3000-in-af-patients-paving-the-way-for-a-new-era-in-atrial-fibrillation-treatment-302305051.html

PR NEWSWIRE
14 Nov 2024

https://www.prnewswire.com/news-releases/huyabio-presents-positive-phase-2-data-on-hbi-8000-and-nivolumab-combination-for-advanced-melanoma-302300026.html

PR NEWSWIRE
08 Nov 2024

https://www.prnewswire.com/news-releases/huyabio-files-an-investigational-new-drug-application-with-the-fda-for-the-novel-shp2-inhibitor-hbi-2376-301365878.html

PRNEWSWIRE
31 Aug 2021

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Contact HUYA Bioscience International and get a quotation

HUYA Bioscience International is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Chidamide bulk offered by HUYA Bioscience International

Find a price of Tucidinostat bulk offered by HUYA Bioscience International

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty